By apyxmedical In 2024 Shareholder News, J-Plasma, RenuvionPosted January 22, 2024APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted October 2, 2023APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON NOVEMBER 9, 2023 READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted August 10, 2023APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND REAFFIRMS FULL YEAR 2023 FINANCIAL OUTLOOK READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted May 11, 2023APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL YEAR 2023 FINANCIAL OUTLOOK READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted March 16, 2023APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2023 FINANCIAL OUTLOOK READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted February 16, 2023APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIAL RESULTS ON MARCH 16, 2023 READ MORE
By apyxmedical In 2023 Shareholder News, RenuvionPosted January 25, 2023APYX MEDICAL CORPORATION LAUNCHES NEW ‘APYX ONE CONSOLE’ FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES READ MORE
